Clinical Trials
20
Active:1
Completed:15
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Tofacitinib Registry of Patients With Ulcerative Colitis in Germany
Terminated
- Conditions
- BiologicsBowel DiseaseChronic Inflammatory Small Bowel DiseaseBowel Diseases, InflammatoryTofacitiniibColitis, UlcerativeCED
- First Posted Date
- 2019-07-25
- Last Posted Date
- 2021-10-08
- Lead Sponsor
- Ced Service GmbH
- Target Recruit Count
- 50
- Registration Number
- NCT04032756
- Locations
- 🇩🇪
Gastroenterologische Gemeinschaftspraxis Minden, Minden, Niedersachsen, Germany
TARGET Registry A Project of the German Network for Intestinal Diseases in Cooperation With Other Corporate Partners
- Conditions
- Indeterminate ColitisUlcerative ColitisCrohn Disease
- First Posted Date
- 2019-07-24
- Last Posted Date
- 2019-07-29
- Lead Sponsor
- Ced Service GmbH
- Target Recruit Count
- 4400
- Registration Number
- NCT04031482
Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany
- Conditions
- Inflammatory Bowel DiseasesTreatment
- First Posted Date
- 2017-12-18
- Last Posted Date
- 2017-12-18
- Lead Sponsor
- Ced Service GmbH
- Target Recruit Count
- 2500
- Registration Number
- NCT03375424
- Locations
- 🇩🇪
Gastroenterologische Gemeinschaftspraxis Minden, Minden, Niedersachsen, Germany
Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease
- Conditions
- Crohn Disease
- First Posted Date
- 2017-04-11
- Last Posted Date
- 2018-07-13
- Lead Sponsor
- Ced Service GmbH
- Target Recruit Count
- 900
- Registration Number
- NCT03108326
- Locations
- 🇩🇪
Gastroenterologische Gemeinschaftspraxis Minden, Minden, Niedersachsen, Germany
News
No news found